Wed, Jul 23, 2014, 8:31 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

  • reeves0527 reeves0527 Aug 5, 2011 6:04 PM Flag

    Well know Biotech Analyst Jason Napodano

    today tweeted that NBIX is a great long term play. This was his quote.


    JNapodanoJason Napodano, CFA

    $NBIX at $6.68 is a great long-term play. Elagolix is a blockbuster drug, they have a ton of cash, and $ABT as a commercial partner.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for posting

      There are a significant number of value creating pipeline events over the next 18 months.

      Two event that are on my radar for FY12 is VMAT2 (NBI-96854) moving into a P1 trial for schizophrenia a blockbuster indication for this program and a P2 read-out for Tardive Dyskinesia. NBIX only plans to partner this drug outside of North America, thus keeping U.S. rights.

 
NBIX
13.71+0.16(+1.18%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.